Trials / Conditions / Influenza Viral Infections

Influenza Viral Infections

20 registered clinical trials studyying Influenza Viral Infections — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Reducing Respiratory Virus Transmission in Bangladeshi Classrooms NCT06247059	Stanford University	N/A
Not Yet Recruiting	Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine NCT06800950	Institute of Medical Biology, Chinese Academy of Medical Sciences	Phase 3
Active Not Recruiting	Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine NCT06622590	Institute of Medical Biology, Chinese Academy of Medical Sciences	Phase 1
Completed	Single Dose Texas 2017 (H3N2) Challenge Study NCT06476275	Duke University	Phase 1
Unknown	Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID NCT06175468	China Medical University Hospital	Phase 3
Unknown	Impact on Influenza Vaccination Rates of a Telephone Text Message Recall From the Attending Physician NCT06123936	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Infection Watch Study NCT04623047	Duke University	—
Completed	Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study NCT05794412	University Hospital, Geneva	—
Completed	Safety, Tolerability and Prophylactic Antiviral Activity of Neumifil Against Influenza Via a Human Viral Chall NCT05507567	Pneumagen Ltd.	Phase 2
Completed	Influenza and Pertussis Vaccination Status of Women in Immediate Postpartum and Caregivers NCT05234229	Central Hospital, Nancy, France	—
Completed	Hypothesizing the Genesis of Infectious Diseases and Epidemics Through an Integrated Systems Biology Approach NCT05557539	Cliniques universitaires Saint-Luc- Université Catholique de Louvain	N/A
Unknown	Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children NCT05739474	St. Petersburg Research Institute of Vaccines and Sera	Phase 3
Active Not Recruiting	An Effectiveness Trial to Evaluate Protection of Children and Pregnant Women by Influenza Vaccine in Rural Ban NCT04998344	University of Bergen	Phase 4
Completed	Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vac NCT05869201	St. Petersburg Research Institute of Vaccines and Sera	Phase 2 / Phase 3
Terminated	Analytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Manageme NCT05105191	Erasme University Hospital	N/A
Completed	Nasal Swab Home Collection Kit (NSHC Kit) Study NCT03813966	University of Wisconsin, Madison	—
Unknown	Effectiveness of Trivalent Inactivated Influenza Maternal Vaccination Among Pregnant Women and Their Newborns NCT02465190	National Institute for Communicable Diseases, South Africa	—
Completed	Intradermal Influenza Vaccine in the Young NCT02103023	The University of Hong Kong	Phase 3
Completed	Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemothera NCT01666782	Saad Jamshed MD	Phase 2
Completed	Severe Acute Respiratory Infections (SARI) in Belgium (2011-2020) NCT05620953	Sciensano	—